Age, Medication, and Lifestyle Readiness Semaglutide is approved for adults 18 and older, but candidacy depends on maturity and commitment to long-term lifestyle change
National Academy Press, Washington, D.Caccessed on 10 Sept European Food Safety Authority (EFSA) (2014) Scientific Opinion on Dietary Reference Values for iodine
In this article, we break down the science behind each medication, how they work, who theyre best for, and what kind of results you can expect

Heres what ophthalmologists want you to know, American Academy of Ophthalmology (2024) Eye stroke Penn Ophthalmology, Penn Medicine Non-arteritic anterior ischemic optic neuropathy (NAION), Brigham and Womens Hospital Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide, JAMA Ophthalmology (2024) Diabetic retinopathy: Causes, symptoms, treatment, American Academy of Ophthalmology (2023) Semaglutide and the risk of diabetic retinopathycurrent perspective, Eye (2022) The effect of glucagon-like peptide-1 receptor agonists on diabetic retinopathy at a tertiary care center, Ophthalmology Science (2024) Semaglutide-eye-catching results, World Journal of Diabetes (2023) Macular edema, National Eye Institute (2023) Impact of GLP-1 agonists and SGLT-2 inhibitors on diabetic retinopathy progression: An aggregated electronic health record data study, American Journal of Ophthalmology (2024) Possible side effects of Ozempic (semaglutide) injection, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
